Received Oct 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
felt very lousy; Headache; entire body muscle aching; Bedridden for10 hours; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, 12 hrs after receiving Arexvy, the patient experienced feeling bad (Verbatim: felt very lousy), headache (Verbatim: Headache), generalized muscle aches (Verbatim: entire body muscle aching) and bedridden (Verbatim: Bedridden for10 hours). The patient was treated with paracetamol (Tylenol). The outcome of the feeling bad, headache and generalized muscle aches were resolved and the outcome of the bedridden was resolved (duration 10 hrs). It was unknown if the reporter considered the feeling bad, headache, generalized muscle aches and bedridden to be related to Arexvy. It was unknown if the company considered the feeling bad, headache, generalized muscle aches and bedridden to be related to Arexvy. Additional Information: GSK Receipt Date: 03-SEP-2025 The reporter reported that it was easy to get the vaccine , however the patient felt very lousy 12 hours later. The patient experienced headache and entire body muscle aching and was bedridden for 10 hours. It was all good now and patient took Ibprophen and Tylenol.